Clinical Trial

Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR

Name: Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR — clinical trial record (NCT07751965)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MARVELTAVI

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Prospective study is designed to evaluate the safety and efficacy of Myval THV series in patients with severe symptomatic non- or mild-calcified aortic regurgitation.

Trial Details

NCT Number	NCT07751965
Lead Sponsor	Ceric Sàrl
Conditions	Aortic Regurgitation, Aortic Disease, Calcified Aortic Valve
Enrollment	164 participants
Start Date	2026-10-30
Primary Completion	2027-12-30 (estimated)
Study Completion	2032-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-07